Potassium citrate + citric acid
Potassium citrate + citric acid has been studied in 1 paper since 2000: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Nov 1, 2000: “Citrate therapy for polycystic kidney disease in rats”.
None of its findings points the other way.
- 1 lab
- Animals1
What did studies of Potassium citrate + citric acid find?
2Studies of Potassium citrate + citric acid measured 2 outcomes; the most studied are lifespan (1 study) and glomerular filtration rate (1).
Lifespan
upin rats1
1 study
Lifespan
upin rats1
Potassium citrate + citric acid extends lifespan in rats (from 10 to 17 months).
“Long-term KCitr treatment extended the average life span of rats with PKD from 10 to 17 months.”
Animalspolycystic kidney diseasemales
Citrate therapy for polycystic kidney disease in rats
Kidney international
Glomerular filtration rate
upin rats1
1 study
Glomerular filtration rate
upin rats1
Potassium citrate + citric acid improves glomerular filtration rate in rats (normal vs one third of normal).
“The GFRs of rats with PKD that consumed KCitr from one month of age were normal at six months of age, while those of their counterparts on water were about one third of normal.”
Animalspolycystic kidney diseasekidneymales
Citrate therapy for polycystic kidney disease in rats
Kidney international